Health & Fitness
Health and Fitness
Health and Fitness
Thu, August 25, 2011
Wed, August 24, 2011
Tue, August 23, 2011 Fibrocell Science, Inc. to Host Investor Conference Call to Discuss Business Update
EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Companya™s Chairman and CEO, will host an investor conference call to discuss Fibrocella™s business update and growth strategy on Wednesday, August 24, 2011 at 4:30 PM Eastern Time.
Fibrocell invites all interested parties to join the call by dialing 888-500-6974 for domestic participants and 719-457-2657 for international participants. The call will also be broadcast live over the Internet and can be accessed on the Investors section of the Companya™s website at [ www.fibrocellscience.com ].
A telephone replay will be available for two weeks following the call by dialing 877-870-5176 for domestic participants and 858-384-5517 for international participants. When prompted, please enter replay pin number 7372734. For those who are not available to listen to the live webcast, the call will be archived for 90 days on Fibrocella™s website.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].
